Hi-Tech Valerian-RX 90 Tablets Herbs Hi-Tech Pharmaceuticals  (4432544038977)

Hi-Tech Pharmaceuticals

Hi-Tech Valerian-RX 90 Tablets

Sale price$29.95 Regular price$29.99
Save $0.04
  |  
SKU: 811836024425
Most USA Orders Ship Free Over $99
Excludes drinks, liquids, bars, and foods.
In stock
Quantity:
Pickup available at Supplement Warehouse Store Usually ready in 4 hours

Hi-Tech Valerian-RX 90 Tablets

Supplement Warehouse Store

Pickup available, usually ready in 4 hours

181 West Crossroads Parkway
Suite F
Bolingbrook IL 60440
United States

+18775051777

Hi-Tech Valerian-RX 90 Tablets | Insomnia & Anxiety

Valerian is an herb native to Europe and parts of Asia, but which also grows in North America, and is often used for medicine and supplements. Valerian is most commonly used for anxiety, relaxation and sleep disorders. Hi-Tech Pharmaceuticals Valerian-RX features 400mg per tablet along with Cyclosome Delivery for enhanced bioavailability.

Hi-Tech Valerian-Rx Highlights

  • Popular Remedy for Insomnia
  • Often Used for Anxiety
  • Often Used to Minimize Hot Flashes
  • Soothes Physical and Mental Tension
  • 400mg Per Tablet
  • Featuring Cyclosome Delivery

Directions

Take 1-2 tablets for relaxation. Take an hour prior to going to sleep. Do not exceed more than 3 tablets within a 24 hour period. 

Hi-Tech Valerian-RX Supplement Facts

 

 

Warnings

Do not exceed recommended dose. Consult a healthcare professional before use if you are pregnant, nursing or taking any sedatives or tranquilizers. Avoid alcohol and do not drive or operate machinery while taking this product. Store in a cool dry place. Keep out of reach of children. 

References

Bent S, Padula A, Moore D, Patterson M, Mehling W. Valerian for sleep: a systematic review and meta-analysis. Am J Med. 2006;119(12):1005–1012. doi:10.1016/j.amjmed.2006.02.026

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394901/

Barton DL, Atherton PJ, Bauer BA, et al. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). J Support Oncol. 2011;9(1):24–31. doi:10.1016/j.suponc.2010.12.008

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052692/